Tidal peritoneal dialysis versus ultrafiltration in type 1 cardiorenal syndrome: A prospective randomized study.

CONCLUSION: Tidal peritoneal dialysis is a safe and effective means for removing toxins and large quantities of excess fluid from patients with intractable heart failure. In patients with cardiorenal syndrome type 1, the use of tidal peritoneal dialysis was superior to ultrafiltration therapy for the preservation of renal function, improvement of cardiac function, and net fluid loss. Ultrafiltration therapy was associated with a higher rate of adverse events.
PMID: 31303099 [PubMed - as supplied by publisher]

Source: The International Journal of Artificial Organs - July 14, 2019 Category: Transplant Surgery Authors: Al-Hwiesh AK, Abdul-Rahman IS, Al-Audah N, Al-Hwiesh A, Al-Harbi M, Taha A, Al-Shahri A, Ghazal S, Amir R, Al-Audah N, Mansour H, El-Mansouri M, El-Salamony TS, Nasr El-Din MA, Noor A, Al-Elq Z, Alzahir ZH, Alzawad NA Tags: Int J Artif Organs Source Type: research